Ischaemic Heart Diseases. Other acute ischemic heart diseases
Conditions
Interventions
Intervention 1: Eye Mask Group:
For this group of patients, in addition to routine care, eye mask (made of black cloth) will be used from 22 pm on the third day of hospitalization to 7 am of next day
Prevention
Eye Mask Group:
For this group of patients, in addition to routine care, eye mask (made of black cloth) will be used from 22 pm on the third day of hospitalization to 7 am of next day.
Ear Plugs Group:
For this group of patients, in addition to routine care, the ear plug (Elvex Mark? Quattro model, four-step ?lace) will be used from 22 pm on the third day of hospitalization to 7
Ear Plugs and Eye Mask Group:
For this group of patients, in addition to routine care, eye mask and ear plug will be used from 22 pm on the third day of hospitalization to 7 am of next day simultaneo
Control group, without any intervention.
Sponsors
Deputy of Research and Technology
Eligibility
Sex/Gender
All
Age
17 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age between 18 and 65 years old, consciousness, orientation to time and place, have no sleep disorders, have no visual and hearing problem, the absence of psychiatric disorders, have no history of night-shift work at least in past 3 years, no use of coffee, alcohol and hypnotic medication at least 12 hours before the study time. Exclusion criteria: Occurrence of sleep disorders during study period (such as sleep apnea, narcolepsy, restless leg syndrome), use of hypnotic medication during study period, the onset of menstruation in female patients during the study, patients who will be discharged or died during the study, sleeping confounding medications (e.g., opiates, amphetamines), receive tranquilizers and anesthetics, cardiopulmonary resuscitation during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep. Timepoint: Before and a day after intervention. Method of measurement: Verran and Snyder Halpern Sleep Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Melatonin. Timepoint: Before and a day after intervention. Method of measurement: The measurement of urinary melatonin.;Cortisol. Timepoint: Before and a day after intervention. Method of measurement: The measurement of urinary cortisol. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomayeh Rezvani Khorshidi
Golestan University of Medical Sciences
Outcome results
None listed